June 29 (Reuters) – Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said on Monday.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
UPDATE 3-Japan Q2 growth misses forecasts on weaker spending, investment
* April-June GDP rises annualised 1.1% vs f'cast 2.0% * Consumption flat, capex down 1.2%…
American actress Hayden Panettiere dies at 36, ABC News reports
Aug 16 (Reuters) - American actress Hayden Panettiere, known for her roles in TV shows…
German companies cut US investment to three-year low, data show
By Rene Wagner BERLIN, Aug 16 (Reuters) - German companies slashed investments in the United…
